期刊文献+

清热化痰方药治疗慢性阻塞性肺疾病急性加重期痰热壅肺证69例临床观察 被引量:41

Treatment of Acute Embittering Chronic Obstructive Pulmonary Disease with Heat-clearing and Phlegm-dissolving Formulas:Clinical Observation on 69 Cases with Phlegm Heat in the Lung
原文传递
导出
摘要 目的评价清热化痰方药对慢性阻塞性肺疾病急性加重期(AECOPD)痰热壅肺证患者的临床疗效。方法选取AECOPD患者140例,随机分为试验组和对照组,两组均参照《慢性阻塞性肺疾病诊治指南》的急性加重治疗方案实施,试验组在以上治疗的基础上,给予清热化痰方药,对照组给予安慰剂。7天为1个疗程,共观察2个疗程。观察患者临床综合疗效、单个症状疗效、实验室指标及生存质量。结果两组患者共脱落6例,试验组69例,总显效57例占82.6%;对照组65例,总显效34例占52.4%,临床综合疗效比较差异有统计学意义(P<0.05)。在咳嗽、咯痰、胸闷、喘息、食欲不振5个症状方面试验组疗效优于对照组(P<0.05)。试验组可改善患者的肺功能、促进炎症的吸收、提高生存质量(P<0.05或P<0.01)。结论清热化痰方药治疗AECOPD痰热壅肺证患者临床疗效确切,可明显改善临床症状和肺功能,提高生存质量。 Objective To evaluate comprehensively the effect of Qingre Huatan Formula (formula for heat-clearing and phlegm-dissolving) on the phlegm heat in lung of acute embittering chronic obstructive pulmonary disease (AECOPD). Methods Totally 140 AECOPD patients were randomized into test group and control group,both were treated according to the Guide on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease,additionally,the test group was administered heat-clearing and phlegm-dissolving formulas,while the control group was given placebo,7 days as one course of treatment,totally for 2 courses. The comprehensive effect,single symptom effect,lab indices,and survival quality were observed. Results The dropout of two groups was 6 cases in all. Of the 69 cases in the test group,57 (82.6%) were remarkably effective; of the 65 cases in the control group,34 (52.4%) were remarkably effective. There was statistical difference in the comprehensive effect between (P〈0.05). In improving the symptoms including cough,expectoration,fullness in chest,asthmatic breathing,and poor appetite,the effect of the test group was better than that of the control group (P〈0.05). In the test group,there existed an improvement of lung function,promotion of absorption of inflammation,and promotion of survival quality (P〈0.05 or P〈0.01). Conclusion Qingre Huatan Formula is effective in treating AECOPD,significantly improving the clinical symptoms and lung function in enhancing the survival quality.
出处 《中医杂志》 CSCD 北大核心 2011年第3期203-207,共5页 Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助(30772797)
关键词 清热化痰方 慢性阻塞性肺疾病 急性加重期 痰热壅肺证 临床疗效 Qingre Huatan Formula (formula for heat-clearing and phlegm-dissolving) chronic obstructive pulmonary disease acute embittering stage phlegm heat in lung clinical effect
  • 相关文献

参考文献11

  • 1Jones PW, Willits LR, Burge PS, et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations[J]. Eur Respir J, 2003,21(1):68- 73.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8237
  • 3Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease[EB/ OL]. 2006 [2009- 12- 01]. http://www, goldcopd. com/GuidelineItem, asp? intId = 1815.
  • 4Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD..a summary the ATS/ERS position paper[J]. Eur Respir J, 2004,23(6) 932 - 946.
  • 5黄文东.实用中医内科学[M].上海:上海科技出版社,1998.476.
  • 6王至婉,李建生,王明航,余学庆,李彬,侯振昆,张艳霞,乔翠霞.慢性阻塞性肺疾病急性加重期中医证候分布规律的文献研究[J].中医杂志,2008,49(8):727-730. 被引量:66
  • 7World Health Organization . WHO Quality of Life-BREF ( WHOQOL-BREF ) [EB/OL ]. 2004 [ 2009 -- 09 -- 10 ]. http..//www, who. int/substance- abuse/researchtools/whoqolbref/en/.
  • 8方宗君,蔡映云,王丽华,梁永杰,陈建荣,邓星奇.慢性阻塞性肺疾病患者生存质量测评表及应用[J].现代康复,2001,5(4):7-8. 被引量:180
  • 9KovelisD SegrettiNO ProbstVS etal.Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease .J Bras Pneumol,2008,34(12):1008-1018.
  • 10王家良.临床流行病学--临床科研与设计、衡量与评价[M].2版.上海:上海科学技术出版社.2002:68-69.

二级参考文献21

共引文献8477

同被引文献593

引证文献41

二级引证文献1877

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部